Researchers at Shanghai Huashan Hospital have identified a novel therapeutic target that could lead to the world's first ...

Researchers suggest drugs that prevent cholesterol from being converted to 24-OHC might therefore be an effective treatment for Parkinson's disease.

The company signed the agreement with Karolinska Institutet's Department of Cell and Molecular Biology professor Johan ...

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and ...

Human induced pluripotent stem cells (iPSCs) can be derived directly from adult ... two cell types implicated in Alzheimer’s ...

Furthermore, it is known that miRNAs act as oncogenes or tumor suppressors and that they regulate essential molecular pathways such as transcription factors involved in the pluripotency phenotype of ...

is a feasible and safe addition to preventing graft-versus-host disease in patients undergoing stem cell transplantation for blood cancers. The study, published Jan. 25 in Nature Communications, is ...

The University of Tasmania will today launch a free Massive Open Online Course (MOOC) on Parkinson's Disease. The course — developed by the University's Wicking Dementia Research and Education ...

Nicotinamide riboside was provided by Evandro Fei Fang (University of Oslo, Norway). The cells were seeded in six-well plates and treated with metformin (Sigma-Aldrich, St. Louis, MO, United States) ...

Parkinson’s Disease - Medical world ... are reprogrammed to so called induced pluripotent (capable of differentiating into one of many cell types) stem cells (iPSCs), and then differentiated ...

aNSC: Adult neural stem cell; BM: Bone marrow ... in the striatum can improve motor symptoms in animal models and Parkinson's disease (PD) patients. Open-label clinical studies using fetal ...